Regulatory PathRegulatory requirements compared

Active substances

Amlodipine + Indapamide + Perindopril

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
Pratima Trio10,10,2.5 mg,mg,mgFilm-coated tablet · Oral use30 BlisterSAR 150.40Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Pratima Trio10,2.5,5 mg,mg,mgFilm-coated tablet · Oral use30 BlisterSAR 138.65Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Pratima Trio5,1.25,5 mg,mg,mgFilm-coated tablet · Oral use30 BlisterSAR 83.20Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Pratima Trio5,1.25,10 mg,mg,mgFilm-coated tablet · Oral use30 BlisterSAR 94.95Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Valid
Triplixam5,1.25,5 mg,mg,mgFilm-coated tablet · Oral use30 BottleSAR 83.20NCE · PrescriptionLES LABORATOIRES SERVIERValid
Triplixam10,2.5,5 mg,mg,mgFilm-coated tablet · Oral use30 BottleSAR 133.30NCE · PrescriptionLES LABORATOIRES SERVIERValid
Triplixam5,1.25,10 mg,mg,mgFilm-coated tablet · Oral use30 BottleSAR 94.95NCE · PrescriptionLES LABORATOIRES SERVIERValid
Triplixam10,2.5,10 mg,mg,mgFilm-coated tablet · Oral use30 BottleSAR 133.30NCE · PrescriptionLES LABORATOIRES SERVIERValid
Indications — CHI Daman Drug Formulary

HYPERTENSION

WHO WHO Model List of Essential Medicines (2025)

  • 12.3. Antihypertensive medicines · core
    Essential hypertension
    Oral > Solid > dosage form: 5 mg (arginine) + 5 mg + 1.25 mg; 5 mg (arginine) + 10 mg + 1.25 mg; 10 mg (arginine) + 5 mg + 2.5 mg; 10 mg (arginine) + 10 mg + 2.5 mg

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.